Pyruvate kinase M2 is a PHD3-stimulated coactivator for hypoxia-inducible factor 1

Cell

Volumn 145, Issue 5, 2011, Pages 732-744

  Luo, Weibo ^a   Hu, Hongxia ^a   Chang, Ryan ^a   Zhong, Jun ^a   Knabel, Matthew ^a   O'Meally, Robert ^a   Cole, Robert N ^a   Pandey, Akhilesh ^a   Semenza, Gregg L ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HYPOXIA INDUCIBLE FACTOR 1ALPHA; LACTIC ACID; OXYGEN; PROLINE; PROLYL HYDROXYLASE 3; PYRUVATE KINASE; PYRUVATE KINASE M2; UNCLASSIFIED DRUG;

ARTICLE; CANCER CELL; CONTROLLED STUDY; ENZYME ACTIVITY; FEEDBACK SYSTEM; GENETIC REGULATION; GENETIC TRANSCRIPTION; GLUCOSE METABOLISM; HUMAN; HUMAN CELL; HYDROXYLATION; OXYGEN CONSUMPTION; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN FUNCTION; PROTEIN INTERACTION; TRANSCRIPTION REGULATION;

EID: 79957567239     PISSN: 00928674     EISSN: 10974172     Source Type: Journal    
DOI: 10.1016/j.cell.2011.03.054     Document Type: Article

References (32)

1. Z. Arany, L.E. Huang, R. Eckner, S. Bhattacharya, C. Jiang, M.A. Goldberg, H.F. Bunn, and D.M. Livingston An essential role for p300/CBP in the cellular response to hypoxia Proc. Natl. Acad. Sci. USA 93 1996 12969 12973 (Pubitemid 26382753)
2. E. Berra, E. Benizri, A. Ginouvs, V. Volmat, D. Roux, and J. Pouysségur HIF prolyl-hydroxylase 2 is the key oxygen sensor setting low steady-state levels of HIF-1α in normoxia EMBO J. 22 2003 4082 4090 (Pubitemid 37021737)
3. H.R. Christofk, M.G. Vander Heiden, M.H. Harris, A. Ramanathan, R.E. Gerszten, R. Wei, M.D. Fleming, S.L. Schreiber, and L.C. Cantley The M2 splice isoform of pyruvate kinase is important for cancer metabolism and tumour growth Nature 452 2008 230 233 (Pubitemid 351380249)
4. C.J. David, M. Chen, M. Assanah, P. Canoll, and J.L. Manley HnRNP proteins controlled by c-Myc deregulate pyruvate kinase mRNA splicing in cancer Nature 463 2010 364 368
5. J.D. Dombrauckas, B.D. Santarsiero, and A.D. Mesecar Structural basis for tumor pyruvate kinase M2 allosteric regulation and catalysis Biochemistry 44 2005 9417 9429 (Pubitemid 40962040)
6. A.C. Epstein, J.M. Gleadle, L.A. McNeill, K.S. Hewitson, J. O'Rourke, D.R. Mole, M. Mukherji, E. Metzen, M.I. Wilson, and A. Dhanda C. elegans EGL-9 and mammalian homologs define a family of dioxygenases that regulate HIF by prolyl hydroxylation Cell 107 2001 43 54 (Pubitemid 32972036)
7. R. Fukuda, H. Zhang, J.W. Kim, L. Shimoda, C.V. Dang, and G.L. Semenza HIF-1 regulates cytochrome oxidase subunits to optimize efficiency of respiration in hypoxic cells Cell 129 2007 111 122 (Pubitemid 46507584)
8. R.A. Gatenby, and R.J. Gillies Why do cancers have high aerobic glycolysis? Nat. Rev. Cancer 4 2004 891 899 (Pubitemid 39472955)
9. A.L. Harris Hypoxia - a key regulatory factor in tumour growth Nat. Rev. Cancer 2 2002 38 47 (Pubitemid 37328806)
10. T. Hitosugi, S. Kang, M.G. Vander Heiden, T.W. Chung, S. Elf, K. Lythgoe, S. Dong, S. Lonial, X. Wang, and G.Z. Chen Tyrosine phosphorylation inhibits PKM2 to promote the Warburg effect and tumor growth Sci. Signal. 2 2009 ra73
11. B.H. Jiang, J.Z. Zheng, S.W. Leung, R. Roe, and G.L. Semenza Transactivation and inhibitory domains of hypoxia-inducible factor 1α. Modulation of transcriptional activity by oxygen tension J. Biol. Chem. 272 1997 19253 19260 (Pubitemid 27337716)
12. W.G. Kaelin Jr., and P.J. Ratcliffe Oxygen sensing by metazoans: the central role of the HIF hydroxylase pathway Mol. Cell 30 2008 393 402 (Pubitemid 351681994)
13. J. Köditz, J. Nesper, M. Wottawa, D.P. Stiehl, G. Camenisch, C. Franke, J. Myllyharju, R.H. Wenger, and D.M. Katschinski Oxygen-dependent ATF-4 stability is mediated by the PHD3 oxygen sensor Blood 110 2007 3610 3617 (Pubitemid 350159628)
14. D. Lando, D.J. Peet, D.A. Whelan, J.J. Gorman, and M.L. Whitelaw Asparagine hydroxylation of the HIF transactivation domain a hypoxic switch Science 295 2002 858 861 (Pubitemid 34118367)
15. D. Li, M. Hirsilä, P. Koivunen, M.C. Brenner, L. Xu, C. Yang, K.I. Kivirikko, and J. Myllyharju Many amino acid substitutions in a hypoxia-inducible transcription factor (HIF)-1α-like peptide cause only minor changes in its hydroxylation by the HIF prolyl 4-hydroxylases: substitution of 3,4-dehydroproline or azetidine-2-carboxylic acid for the proline leads to a high rate of uncoupled 2-oxoglutarate decarboxylation J. Biol. Chem. 279 2004 55051 55059 (Pubitemid 40066497)
16. W. Luo, J. Zhong, R. Chang, H. Hu, A. Pandey, and G.L. Semenza Hsp70 and CHIP selectively mediate ubiquitination and degradation of hypoxia-inducible factor (HIF)-1α but not HIF-2α J. Biol. Chem. 285 2010 3651 3663
17. G. Melillo Targeting hypoxia cell signaling for cancer therapy Cancer Metastasis Rev. 26 2007 341 352 (Pubitemid 47101663)
18. T. Noguchi, H. Inoue, and T. Tanaka The M1- and M2-type isozymes of rat pyruvate kinase are produced from the same gene by alternative RNA splicing J. Biol. Chem. 261 1986 13807 13812 (Pubitemid 17196407)
19. N. Pescador, Y. Cuevas, S. Naranjo, M. Alcaide, D. Villar, M.O. Landázuri, and L. Del Peso Identification of a functional hypoxia-responsive element that regulates the expression of the egl nine homologue 3 (egln3/phd3) gene Biochem. J. 390 2005 189 197 (Pubitemid 41192244)
20. T.N. Seagroves, H.E. Ryan, H. Lu, B.G. Wouters, M. Knapp, P. Thibault, K. Laderoute, and R.S. Johnson Transcription factor HIF-1 is a necessary mediator of the Pasteur effect in mammalian cells Mol. Cell. Biol. 21 2001 3436 3444 (Pubitemid 32381779)
21. G.L. Semenza Targeting HIF-1 for cancer therapy Nat. Rev. Cancer 3 2003 721 732 (Pubitemid 37328811)
22. G.L. Semenza Defining the role of hypoxia-inducible factor 1 in cancer biology and therapeutics Oncogene 29 2010 625 634
23. G.L. Semenza, B.H. Jiang, S.W. Leung, R. Passantino, J.P. Concordet, P. Maire, and A. Giallongo Hypoxia response elements in the aldolase A, enolase 1, and lactate dehydrogenase A gene promoters contain essential binding sites for hypoxia-inducible factor 1 J. Biol. Chem. 271 1996 32529 32537
24. G.L. Semenza, P.H. Roth, H.M. Fang, and G.L. Wang Transcriptional regulation of genes encoding glycolytic enzymes by hypoxia-inducible factor 1 J. Biol. Chem. 269 1994 23757 23763 (Pubitemid 24293585)
25. 2 tension Proc. Natl. Acad. Sci. USA 92 1995 5510 5514
26. W.W. Wheaton, and N.S. Chandel Hypoxia regulates cellular metabolism Am. J. Physiol. Cell Physiol. 300 2011 C385 C393
27. 2)-adrenergic receptor hydroxylation by EGLN3 and ubiquitylation by pVHL Sci. Signal. 2 2009 ra33
28. H. Zhang, D.Z. Qian, Y.S. Tan, K. Lee, P. Gao, Y.R. Ren, S. Rey, H. Hammers, D. Chang, and R. Pili Digoxin and other cardiac glycosides inhibit HIF-1α synthesis and block tumor growth Proc. Natl. Acad. Sci. USA 105 2008 19579 19586
29. Kondo, K., Kim, W.Y., Lechpammer, M., and Kaelin, W.G., Jr. (2003). Inhibition of HIF2alpha is sufficient to suppress pVHL-defective tumor growth. PLoS Biol. 1, E83.
30. Krishnamachary, B., Zagzag, D., Nagasawa, H., Rainey, K., Okuyama, H., Baek, J.H., and Semenza, G.L. (2006). Hypoxia-inducible factor-1-dependent repression of E-cadherin in von Hippel-Lindau tumor suppressor-null renal cell carcinoma mediated by TCF3, ZFHX1A, and ZFHX1B. Cancer Res. 66, 2725-2731.
31. 2-independent and HSP90 inhibitor-induced degradation of HIF-1α. Mol. Cell 25, 207-217. (Pubitemid 46109612)
32. Okuyama, H., Krishnamachary, B., Zhou, Y.F., Nagasawa, H., Bosch-Marce, M., and Semenza, G.L. (2006). Expression of vascular endothelial growth factor receptor 1 in bone marrow-derived mesenchymal cells is dependent on hypoxia-inducible factor 1. J. Biol. Chem. 281, 15554-15563. (Pubitemid 43855148)